Correction to: LncRNA MYLK-AS1 facilitates tumor progression and angiogenesis by targeting miR-424-5p/E2F7 axis and activating VEGFR-2 signaling pathway in hepatocellular carcinoma

Detalles Bibliográficos
Autores principales: Teng, Fei, Zhang, Ju-Xiang, Chang, Qi-Meng, Wu, Xu-Bo, Tang, Wei-Guo, Wang, Jian-Fa, Feng, Jin-Feng, Zhang, Zi-Ping, Hu, Zhi-Qiu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7724876/
https://www.ncbi.nlm.nih.gov/pubmed/33298087
http://dx.doi.org/10.1186/s13046-020-01780-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7724876/
https://www.ncbi.nlm.nih.gov/pubmed/33298087
http://dx.doi.org/10.1186/s13046-020-01780-y

Ejemplares similares